Published in J Immunol on April 28, 2010
Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol Ther (2011) 1.23
Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity. Clin Cancer Res (2010) 1.14
Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles. ACS Nano (2014) 1.10
A novel small-molecule enantiomeric analogue of traditional (-)-morphinans has specific TLR9 antagonist properties and reduces sterile inflammation-induced organ damage. J Immunol (2013) 0.83
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. EMBO Mol Med (2015) 0.80
DNA-polymer conjugates for immune stimulation through Toll-like receptor 9 mediated pathways. Acta Biomater (2013) 0.77
DNA methylation governs the dynamic regulation of inflammation by apoptotic cells during efferocytosis. Sci Rep (2017) 0.75
Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences. Vaccines (Basel) (2016) 0.75
Rational design of cationic lipids for siRNA delivery. Nat Biotechnol (2010) 4.97
Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat Immunol (2003) 2.27
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells. Mol Ther Nucleic Acids (2012) 1.24
Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol Ther (2013) 1.11
Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN. Cancer Immunol Immunother (2007) 1.08
Tails of wonder: endocytic-sorting motifs key for exogenous antigen presentation. Trends Immunol (2005) 1.01
Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res (2005) 0.98
Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival. Clin Cancer Res (2008) 0.91
Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles. Int Immunol (2009) 0.90
Dendritic cell cross-priming is essential for immune responses to Listeria monocytogenes. PLoS One (2009) 0.88
Factors limiting autogene-based cytoplasmic expression systems. FASEB J (2005) 0.87
Using the TAP component of the antigen-processing machinery as a molecular adjuvant. PLoS Pathog (2005) 0.84
The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients. Cancer Immunol Immunother (2004) 0.81
The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine. J Gene Med (2009) 0.78
"Diffusible-PEG-lipid stabilized plasmid lipid particles". Adv Genet (2005) 0.78
"Diffusible-PEG-Lipid Stabilized Plasmid Lipid Particles" Adv Genet (2005) 0.78
Methods for the preparation of protein-oligonucleotide-lipid constructs. Bioconjug Chem (2006) 0.75
The effect of circulation lifetime and drug-to-lipid ratio of intravenously administered lipid nanoparticles on the biodistribution and immunostimulatory activity of encapsulated CpG-ODN. J Drug Target (2008) 0.75